ArticleCancers2021

Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis.

Emma Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.